Ropharma Bras BVB:RPH -1.6% Consumer Staples SECTOR:STPL.RO 5.4% S.C. Bucur Obor S.A. BVB:BUCU 5.4% Alimentara SA Slatina BVB:ALRV 21.4% Comaliment SA (Resita) BVB:OMAL NM- Bucur SA BVB:BUCV NM- Farmaceutica R BVB:RMAH 18.9% Hongchang International Co Ltd OTCPK:HCIL NM- Mango...
| complement tech | conda | Continental Refrigerator | Cooper-Atkins Corporation | coopersurgical | Coors Ceramicon Design Ltd. | Corden Pharma | cordenpharma | cosmo | cosmo bio | cosmo bioscience | cospheric-microspheres | covalab | covance | covance research products | covaris | covarisinc |...
Pharma Sciences for the implementation China GMP, Chinese Pharmacopeia (CHP) and other China regulatory requirements in PGS sites.02 Partner with PGS for supply strategy to avoid supply issue due to site changes02 Provide regulatory inputs for the approval of promotional materials following applicable...
| alere | alexis | alfa | All Foils Incorporated | allele biotech | allelebiotech | allen-bradley | Allied K&R Broom & Bristle | allstar scientific | alnylam pharmaceuticals | alomone labs | alpco | alpha diagnoestic international | alpha diagnostics | alpha innotech | Alpha Pro Tech, Ltd. ...
major in pharmacebossutical or related major; At least 3 years of experience in pharmaceutical industry; 2) Excellent knowledge and competency in Drug registration and relevant technical guidelines. 3) Good communication skill, creative thinking, with teamwork spirit; Result and detailed oriented and ...
目前，有多家机构在研究靶向IL-2RA（CD25）的药物，包括三生国健药业（上海）股份有限公司、信达生物、Ligand Pharmaceuticals, Inc.、Eisai Co., Ltd.和Novartis Pharma AG等。三种靶向CD25/IL-2RA的药物已经获得批准上市，分别是Daclizumab达克珠单抗和Basiliximab巴利昔单抗（均用于肾移植排斥反应）、Denileukin Dif...
The company cites research by the International Long Term Care Policy Network (LTCPN) which suggests that between 42% and 57% of all deaths related to COVID-19 have so far occurred in nursing homes. “We hope our new companion app will help alleviate the overwhelming pressure being...
目前,有多家机构在研究靶向IL-2RA(CD25)的药物,包括三生国健药业(上海)股份有限公司、信达生物、Ligand Pharmaceuticals, Inc.、Eisai Co., Ltd.和Novartis Pharma AG等。三种靶向CD25/IL-2RA的药物已经获得批准上市,分别是Daclizumab达克珠单抗和Basiliximab巴利昔单抗(均用于肾移植排斥反应)、Denileukin Diftitox...
In the last 2 years, AbbVie, Amgen, AstraZeneca, Genentech, Horizon Pharma, Eli Lilly, Novartis, Pfizer, Vertex and UCB have supported CORRONA through contracted subscriptions. Disclosure of Interest D. Pappas Employee of: CORRONA, Inc., Paid instructor for: Novartis., A. John Employee of: ...
F. Hoffmann-La Roche Ltd.Roche Pharma AG 最高研发阶段批准上市 首次获批日期 日本(2005-04-11), Castleman病 最高研发阶段(中国)批准上市 特殊审评突破性疗法 (美国)、孤儿药 (美国)、孤儿药 (日本)、紧急使用授权 (美国) 登录后查看首次获批时间轴 序列信息 Sequence Code 12264H 来源: *** Sequence...